This paper presents a novel, open access interactive platform for 3D medical image analysis, simulation and visualization, focusing in oncology images. The platform was developed through constant interaction and feedback from expert clinicians integrating a thorough analysis of their requirements while having an ultimate goal of assisting in accurately delineating tumors. It allows clinicians not only to work with a large number of 3D tomographic datasets but also to efficiently annotate multiple regions of interest in the same session. Manual and semi-automatic segmentation techniques combined with integrated correction tools assist in the quick and refined delineation of tumors while different users can add different components related to oncology such as tumor growth and simulation algorithms for improving therapy planning. The platform has been tested by different users and over large number of heterogeneous tomographic datasets to ensure stability, usability, extensibility and robustness with promising results.AvailabilityThe platform, a manual and tutorial videos are available at: .It is free to use under the GNU General Public License.
In this study, we investigated three measures capable of detecting absence seizures with increased sensitivity based on different underlying assumptions. Namely, an information-based method known as Approximate Entropy, a nonlinear alternative (Order Index), and a linear variance analysis approach. The results on the long-term EEG data suggest increased accuracy in absence seizure detection achieving sensitivity as high as 97.33% with no further application of any sophisticated classification scheme.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.